Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04335058
NA

Lactoferrin in Treatment of Fe Deficient Anemia In Cirrhosis

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh

View on ClinicalTrials.gov

Summary

Iron deficiency and altered homeostasis due to inflammation and decreased iron utilization are main factors involved in anemia in liver disease. Lactoferrin is a first line defence protein for protection against microbial infections and subsequent development of systemic disease as seen with systemic inflammatory response syndrome (SIRS) and sepsis. Lactoferrin with iron has been shown to be efficacious with anemia in chronic disease, in pregnancy and in cancer patients with fewer side effects than oral iron alone. High exposure to iron is associated with increased inflammation which is associated with worse cardiovascular outcomes. Lactoferrin can help reduce the total iron dose and hepatic inflammation.

Official title: Lactoferrin With Iron Versus Iron Alone in Treatment of Anemia In Chronic Liver Disease

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

130

Start Date

2020-01-01

Completion Date

2026-12

Last Updated

2026-11-13

Healthy Volunteers

Yes

Interventions

DRUG

Lactoferrin + Iron Supplement

Lactoferrin 100 mg twice daily +oral iron

DRUG

Iron Supplement

Oral iron supplement alone

Locations (1)

Postgraduate Institute of Medical Education and Research

Chandigarh, India